New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice

Published:2021-05 Issue: Volume:167 Page:105562
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Ma Ningning,Fan Lei,Dong Yunxia,Xu Xiaoding,Yu Chuwei,Chen Jing,Ren Jin

Funder

National Major Science and Technology Projects of China

Novo Nordisk AS

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference55 articles.

1. Metabolic syndrome, dyslipidemia and regulation of lipoprotein metabolism;Iqbal;Curr. Diabetes Rev.,2018

2. The different facets of dyslipidemia and hypertension in atherosclerosis;Hurtubise;Curr. Atheroscler. Rep.,2016

3. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II;Gitt;Atherosclerosis,2017

4. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: review of the clinical evidence;Barrios;Atheroscler. Suppl.,2017

5. Reduction of vascular inflammation, LDL-C, or both for the protection from cardiovascular events?;Reklou;Open Cardiovasc. Med. J.,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Passiflora edulis extract ameliorates HFD-induced hepatic steatosis mediated through Nrf2 and IRS-1 activation, NFκB suppression, and hepatic lipid metabolism and bile acid modulation in obese rats;Journal of Functional Foods;2024-09

2. Proanthocyanidins isolated from lotus seed skin mitigate glycolipid metabolism disorder through the p38/Nrf2/NF-κB signaling pathway;Acta Biochimica et Biophysica Sinica;2024-05-01

3. MicroRNA-mediated Regulation of LDL Receptor: Biological and Pharmacological Implications;Current Medicinal Chemistry;2024-04

4. Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management;Journal of Clinical Medicine;2024-02-22

5. Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies—a model-based meta-analysis;Frontiers in Cardiovascular Medicine;2024-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3